Dr. Marini has over 20 years of experience in the pharmaceutical industry.  Before founding Global Bioanalytical Strategies, LLC in 2021, Dr. Marini worked with Johnson & Johnson where he served as a Scientific Director in the Janssen BioTherapeutics (JBIO) division of Janssen Research and Development, LLC since 2001.  Dr. Marini was responsible for developing and implementing bioanalytical strategies for advancing the biologics pipeline.  During his tenure at J&J, Dr. Marini and his team were instrumental in the development and approval of many biologic therapies including Stelara, Simponi, Sylvant, Darzalex and Tremfya. Dr. Marini was also an active leader in the American Association of Pharmaceutical Scientists and the European Bioanalysis Forum. 

Dr. Marini received his Bachelor of Arts degree in Biology at the University of Pennsylvania (Philadelphia, PA, USA) and his Ph.D. in Immunology at Thomas Jefferson University (Philadelphia, PA, USA).  Joe completed his post-doctoral training at the Kennedy Institute of Rheumatology, University of Oxford (Oxford, UK).